Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Goldman Sachs has led a $147m funding round for cybersecurity developer Acronis, pushing the company’s valuation beyond the $1bn mark.

Edgewise Therapeutics completed a $50m round co-led by Novo that will advance product candidates addressing Duchenne and Becker muscular dystrophy.

Automated driving systems manufacturer CalmCar collected $14m from a SAIC Motor subsidiary and Beijing Connected Vehicles Development Fund having previously been backed by BAIC and China Unicom among others.

The diabetes management app developer raised $40m in a round led by Bayer, which has also signed a licensing agreement with the company.

Riverain Technologies raised the cash in a round led by Ping An Global Voyager Fund and will use the cash to expands its lung cancer diagnostics technology.

The cancer care platform developer secured funding in a series D round co-led by Merck Global Health Innovation Fund and backed by LabCorp.

Lilly Asia Ventures has returned for the genomic drug developer's latest round, having already taken part in a $15m pre-series B round just over a year ago.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Existing shareholder Goldman Sachs has co-led a $268m series E round for GitLab that valued the GV-backed software development platform at $2.75bn.